Methods of extended use oral contraception

Details Methods of extended use oral contraception Methods of extended use oral contraception

A - Human Necessities

61

K

A61K 31/567 (2006.01) A61P 15/18 (2006.01)

Patent

CA 2256977

A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include less menstrual bleeding, less patient anemia, less total exposure to medication, higher compliance rates and more lifestyle convenience for patients.

Affiliated with

Also associated with

Rating

Methods of extended use oral contraception does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of extended use oral contraception, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of extended use oral contraception will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1380391